Merit Medical’s SCOUT MD Surgical Guidance System Receives the US FDA’s Approval for the Detection and Treatment of Soft Tissue Cancers
Shots:
- The company received the US FDA’s 510(k) clearance for its SCOUT MD Surgical Guidance System designed to enhance the diagnosis and treatment of soft tissue cancers incl. breast cancer
- The surgical guidance system functions by detecting the tumor location in multiple dimensions upon implantation within the abnormal soft tissues thereby providing a targeted approach to cancer treatment while minimizing the damage to the surrounding healthy tissue
- The approval of SCOUT MD Surgical Guidance System has enhanced the company’s existing diagnosis and treatment portfolio for soft tissue cancers which includes SCOUT Radar Localization System, SCOUT Mini Reflector, SCOUT Bx Delivery System & SAVI Brachy System
Ref: Merit Medical | Image: Merit Medical
Related News:- The US FDA Approves Jaguar Health’s Clinical Trial Protocol for Canalevia-CA1 to Treat Chemotherapy-Induced Diarrhea in Dogs
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
Click here to read the full press release
Tags
Shivani is a content writer at PharmaShots. She has a keen interest in recent innovations in the life sciences industry. She covers news related to Product approvals, clinical trial results, and updates. She can be contacted at connect@pharmashots.com.
